Adaptive Biotechnologies Cash Flow Statement (2018-2025) | ADPT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-40.64M	-49.30M	-56.00M	-61.36M	-62.80M	-52.08M	-45.32M	-40.17M	-57.70M	-47.81M	-50.33M	-69.47M	-47.53M	-46.25M	-32.10M	-33.72M	-29.83M	-25.59M	9.54M	-13.58M
Depreciation and Depletion (Quarter)	2.25M	2.48M	3.10M	4.42M	4.64M	4.77M	4.96M	4.86M	5.00M	5.23M	5.33M	4.93M	4.79M	4.58M	4.16M	4.02M	4.31M	4.08M	3.98M	3.73M
Share-based Compensation (Quarter)	8.48M	11.25M	11.64M	11.88M	12.86M	14.18M	14.14M	14.29M	14.67M	17.34M	15.34M	15.56M	14.30M	12.96M	13.52M	12.83M	12.15M	13.36M	13.26M	12.72M
Gains from Sales and Divestitures (Quarter)		0.01M	0.02M	0.02M	0.14M	0.16M	0.23M	0.30M	1.03M	1.19M	1.30M	1.51M	2.26M	2.33M	2.41M	2.59M	3.01M	3.09M	3.17M	3.36M
Gains from Investment Securities (Quarter)	0.01M	1.99M	12.76M	0.07M	0.02M	14.34M	13.79M	-0.00M	1.61M	14.13M	1.00M	-0.01M	1.01M	12.82M	1.01M	0.35M	11.94M	0.76M	0.76M	-0.10M
Asset Writedowns and Impairment (Quarter)																-5.27M				0.56M
Non-cash Items (Quarter)	109.10M	103.80M	97.60M	96.80M	51.64M	9.55M	4.18M	6.65M	13.65M	2.38M	1.11M	0.51M	0.11M	0.12M	1.37M	2.16M	5.37M	29.36M	15.37M	0.06M
Cash from Operations (Quarter)	-58.24M	-37.21M	-43.44M	-53.83M	-64.45M	-47.06M	-42.41M	-30.02M	-59.15M	-23.56M	-46.68M	-26.93M	-38.35M	-17.30M	-27.07M	-12.49M	-28.48M	-12.43M	-7.13M	2.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.42M	0.42M	0.43M	0.43M	-0.86M	0.42M	0.43M	0.43M	0.42M	0.42M	0.43M	0.43M	0.42M	0.42M	0.43M	6.93M	0.42M	0.42M	0.43M	-0.53M
Depreciation & Amortization (CF) (Quarter)	2.25M	2.48M	3.10M	4.42M	4.64M	4.77M	4.96M	4.86M	5.00M	5.23M	5.33M	4.93M	5.21M	4.57M	4.16M	3.93M	4.73M	4.07M	3.97M	3.65M
Change in Working Capital
Change in Receivables (Quarter)	9.71M	-5.58M	2.95M	0.29M	5.11M	1.19M	2.84M	13.51M	-9.09M	0.62M	-0.33M	6.77M	4.05M	-6.41M	5.20M	0.90M	1.86M	0.70M	0.54M	5.54M
Change in Inventory (Quarter)	3.36M	1.19M	-0.38M	1.03M	1.74M	0.55M	-0.07M	-3.03M	6.61M	-0.07M	0.27M	-3.98M	-1.11M	0.82M	-1.70M	-3.38M	-0.26M	-0.10M	1.35M	0.01M
Change in Accured Expenses (Quarter)	-7.26M	4.78M	7.99M	-1.58M	-7.54M	-1.41M	5.54M	10.53M	-15.88M	7.94M	-2.81M	5.34M	-3.94M	0.41M	-0.06M	4.26M	-9.66M	3.27M	5.90M	1.17M
Other Working Capital Changes (Quarter)	-14.23M	0.02M	0.02M	45.06M	0.05M	0.37M	0.50M	43.85M	-8.49M	0.15M	0.34M	-0.00M	0.07M	0.32M	0.70M	-10.46M	0.05M	0.34M	0.40M	-39.28M
Investing Activities
Capital Expenditures (Quarter)	7.70M	30.18M	14.62M	9.24M	3.08M	5.30M	5.43M	-12.09M	1.65M	4.97M	-5.31M	9.39M	1.51M	-1.20M	3.27M	0.08M	1.26M	0.66M	0.41M	-1.81M
Change in Acquisitions & Divestments (Quarter)	125.00M	144.50M	135.00M	155.00M	101.00M	35.00M	92.00M	70.03M	155.00M	140.40M	148.00M	126.50M	99.50M	90.33M	68.89M	67.00M	77.49M	55.14M	50.88M	39.12M
Cash from Investing Activities (Quarter)	93.82M	41.45M	-21.27M	67.21M	37.69M	4.75M	58.02M	-97.54M	62.98M	37.32M	26.14M	3.21M	44.51M	5.88M	5.29M	22.12M	25.57M	3.35M	17.28M	-8.25M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	14.61M	6.33M	2.93M	3.28M	2.75M	3.99M	125.52M	0.01M	0.67M	1.47M	0.02M	0.09M	0.04M	0.03M	0.04M	0.13M	5.45M	1.61M	1.68M	21.66M
Additional items
Change in Cash (Quarter)	50.19M	10.56M	-61.78M	16.66M	-24.02M	-38.33M	141.13M	-127.56M	4.50M	15.24M	-20.53M	-23.64M	6.20M	-11.40M	-21.74M	9.76M	2.54M	-7.47M	11.84M	15.46M
Free Cash Flow (Quarter)	-65.94M	-67.40M	-58.06M	-63.07M	-67.53M	-52.36M	-47.84M	-17.93M	-60.80M	-28.53M	-41.37M	-36.32M	-39.86M	-16.11M	-30.33M	-12.57M	-29.74M	-13.09M	-7.54M	3.87M
Net Cash Flow (Quarter)	50.19M	10.56M	-61.78M	16.66M	-24.02M	-38.33M	141.13M	-127.56M	4.50M	15.24M	-20.53M	-23.64M	6.20M	-11.40M	-21.74M	9.76M	2.54M	-7.47M	11.84M	15.46M

Research Tools

Adaptive Biotechnologies Cash Flow Statement (2018-2025) | ADPT

Create an account

Sign In

Reset Password